The revival was on the back of therapies, including cardiac and anti-diabetic, which grew by 19.5% and 9.7% respectively in October (over September), according to data from research firm AIOCD Awacs. Respiratory medicines showed marginal improvement at -6.6% in October as against -10.5 % in September.from Industry-Economic Times
Read The Rest:economictimes...
